Therapy options for patients with hepatocellular carcinoma (HCC), including a newly approved therapy for a subpopulation of patient.
Crystal Denlinger, MD, FACP
Advertisement
Articles by Crystal Denlinger, MD, FACP
Advertisement
Latest Updated Articles
Therapy Options for Patients With Hepatocellular CarcinomaSeptember 20th 2019
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts NDA for Daraxonrasib in Pretreated Metastatic Pancreatic Cancer
2
Defining New Thresholds for Precisely Mitigating CAR T Toxicity
3
Novel Agent Begins STARLIGHT-1 Dose Expansion in Relapsed/Refractory B-Cell NHL
4
How to Speak With Patients About Potential Changes to Care During Biopsy Needle Delays
5